Related Experiment Videos
Pharmaceuticals in Medicare reform
1Center on Drugs and Public Policy, School of Pharmacy, University of Maryland, Baltimore, USA.
Clinical Therapeutics
|January 28, 1998
Summary
Reforming Medicare requires balancing prescription drug coverage for seniors against rising costs. A thorough cost-benefit analysis must consider factors beyond just drug prices for effective policy decisions.
Area of Science:
- Health Policy
- Gerontology
- Pharmaceutical Economics
Background:
- Medicare system reforms are under consideration by policymakers.
- Prescription drug coverage for elderly beneficiaries is a key issue.
- Balancing benefit attractiveness with expenditure concerns is crucial.
Purpose of the Study:
- To analyze the costs and benefits of including prescription drug coverage in Medicare.
- To inform policy decisions regarding pharmaceutical benefits for seniors.
- To advocate for a comprehensive cost-benefit examination.
Main Methods:
- Policy analysis of Medicare reform proposals.
- Economic evaluation of prescription drug benefits.
- Review of expenditure data and cost-benefit frameworks.
Main Results:
- Including prescription drug coverage presents both opportunities and challenges.
- Expenditure increases are a significant concern.
- A narrow focus on drug product costs is insufficient for evaluation.
Conclusions:
- Prudent examination of prescription drug coverage requires a broad perspective.
- Policy decisions should integrate a comprehensive understanding of costs and benefits.
- Moving beyond pharmaceutical product costs is essential for Medicare reform.